| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |